Cisplatin and paclitaxel co-delivered by folate-decorated lipid carriers for the treatment of head and neck cancer

References

• Alam MI, Baboota S, Ahuja A, et al. (2013). Intranasal infusion of nanostructured lipid carriers (NLC) containing CNS acting drug and estimation in brain and blood. Drug Deliv 20:247–51
   PubMed Web of Science ®Google Scholar
• Bernkop-Schnürch A, Giovanelli R, Valenta C. (2000). Peroral administration of enzymes: strategies to improve the galenic of dosage forms for trypsin and bromelain. Drug Dev Ind Pharm 26:115–21
   PubMed Web of Science ®Google Scholar
• Ding J, Feng M, Wang F, et al. (2015). Targeting effect of PEGylated liposomes modified with the Arg-Gly-Asp sequence on gastric cancer. Oncol Rep 34:1825–34
   PubMed Web of Science ®Google Scholar
• Doddapaneni R, Patel K, Owaid IH, Singh M. (2016). Tumor neovasculature-targeted cationic PEGylated liposomes of gambogic acid for the treatment of triple-negative breast cancer. Drug Deliv 23:1232–41
   PubMed Web of Science ®Google Scholar
• Dosio F, Arpicco S, Stella B, et al. (2009). Folate-mediated targeting of albumin conjugates of paclitaxel obtained through a heterogeneous phase system. Int J Pharm 382:117–23
   PubMed Web of Science ®Google Scholar
• Duan S, Cai S, Yang Q, Forrest ML. (2012). Multi-arm polymeric nanocarrier as a nitric oxide delivery platform for chemotherapy of head and neck squamous cell carcinoma. Biomaterials 33:3243–53
   PubMed Web of Science ®Google Scholar
• Fang RH, Aryal S, Hu CM, Zhang L. (2010). Quick synthesis of lipid–polymer hybrid nanoparticles with low polydispersity using a single-step sonication method. Langmuir 26:16958–62
   PubMed Web of Science ®Google Scholar
• Fang X, Yang T, Wang L, et al. (2016). Nano-cage-mediated refolding of insulin by PEG-PE micelle. Biomaterials 77:139–48
   PubMed Web of Science ®Google Scholar
• Gabizon A, Horowitz AT, Goren D, et al. (1999). Targeting folate receptor with folate linked to extremities of poly(ethylene glycol)-grafted liposomes: in vitro studies. Bioconjug Chem 10:289–98
   PubMed Web of Science ®Google Scholar
• Golla K, Reddy PS, Bhaskar C, Kondapi AK. (2013). Biocompatibility, absorption and safety of protein nanoparticle-based delivery of doxorubicin through oral administration in rats. Drug Deliv 20:156–67
   PubMed Web of Science ®Google Scholar
• Han Y, Zhang P, Chen Y, et al. (2014). Co-delivery of plasmid DNA and doxorubicin by solid lipid nanoparticles for lung cancer therapy. Int J Mol Med 34:191–6
   PubMed Web of Science ®Google Scholar
• Han Y, Zhang Y, Li D, et al. (2014). Transferrin-modified nanostructured lipid carriers as multifunctional nanomedicine for codelivery of DNA and doxorubicin. Int J Nanomed 9:4107–16
   PubMed Web of Science ®Google Scholar
• Jia Y, Ji J, Wang F, et al. (2016). Formulation, characterization, and in vitro/vivo studies of aclacinomycin A-loaded solid lipid nanoparticles. Drug Deliv 23:1317–25
   PubMed Web of Science ®Google Scholar
• Lv S, Tang Z, Li M, et al. (2014). Co-delivery of doxorubicin and paclitaxel by PEG-polypeptide nanovehicle for the treatment of non-small cell lung cancer. Biomaterials 35:6118–29
   PubMed Web of Science ®Google Scholar
• Oberoi HS, Nukolova NV, Kabanov AV, Bronich TK. (2013). Nanocarriers for delivery of platinum anticancer drugs. Adv Drug Deliv Rev 65:1667–85
   PubMed Web of Science ®Google Scholar
• Pfister DG, Spencer S, Brizel DM, et al. (2014). Head and neck cancers, Version 2.2014. Clinical practice guidelines in oncology. J Natl Compr Canc Netw 12:1454–87
   PubMed Web of Science ®Google Scholar
• Pereira Ade F, Pereira LG, Barbosa LA, et al. (2013). Efficacy of methotrexate-loaded poly(ɛ-caprolactone) implants in Ehrlich solid tumor-bearing mice. Drug Deliv 20:168–79
   PubMed Web of Science ®Google Scholar
• Posner MR. (2010). Integrating systemic agents into multimodality treatment of locally advanced head and neck cancer. Ann Oncol 21:vii246–51
   PubMed Web of Science ®Google Scholar
• Rahman HS, Rasedee A, How CW, et al. (2013). Zerumbone-loaded nanostructured lipid carriers: preparation, characterization, and antileukemic effect. Int J Nanomed 8:2769–81
   PubMed Web of Science ®Google Scholar
• Rowinsky EK, Eisenhauer EA, Chaudhry V, et al. (1993). Clinical toxicities encountered with paclitaxel (Taxol). Semin Oncol 20:1–15
   PubMed Web of Science ®Google Scholar
• Saba NF, Wang X, Müller S, et al. (2009). Examining expression of folate receptor in squamous cell carcinoma of the head and neck as a target for a novel nanotherapeutic drug. Head Neck 31:475–819
   PubMed Web of Science ®Google Scholar
• Shao Z, Shao J, Tan B, et al. (2015). Targeted lung cancer therapy: preparation and optimization of transferrin-decorated nanostructured lipid carriers as novel nanomedicine for co-delivery of anticancer drugs and DNA. Int J Nanomed 10:1223–33
   PubMed Web of Science ®Google Scholar
• Sonali, Agrawal P, Singh RP, et al. (2016). Transferrin receptor-targeted vitamin E TPGS micelles for brain cancer therapy: preparation, characterization and brain distribution in rats. Drug Deliv 23:1788–98
   PubMed Web of Science ®Google Scholar
• Song S, Mao G, Du J, Zhu X. (2016). Novel RGD containing, temozolomide-loading nanostructured lipid carriers for glioblastoma multiforme chemotherapy. Drug Deliv 23:1404–8
   PubMed Web of Science ®Google Scholar
• Soundararajan A, Bao A, Phillips WT, et al. (2009). [(186)Re]Liposomal doxorubicin (Doxil): in vitro stability, pharmacokinetics, imaging and biodistribution in a head and neck squamous cell carcinoma xenograft model. Nucl Med Biol 36:515–24
   PubMed Web of Science ®Google Scholar
• Sun L, Joh DY, Al-Zaki A, et al. (2016). Theranostic application of mixed gold and superparamagnetic iron oxide nanoparticle micelles in glioblastoma multiforme. J Biomed Nanotechnol 12:347–56
   PubMed Web of Science ®Google Scholar
• Tomasina J, Poulain L, Abeilard E, et al. (2013). Rapid and soft formulation of folate-functionalized nanoparticles for the targeted delivery of tripentone in ovarian carcinoma. Int J Pharm 458:197–207
   PubMed Web of Science ®Google Scholar
• Vhora I, Khatri N, Desai J, Thakkar HP. (2014). Caprylate-conjugated Cisplatin for the development of novel liposomal formulation. AAPS PharmSciTech 15:845–57
   PubMed Web of Science ®Google Scholar
• Wang J, Zhang L, Chi H, Wang S. (2016). An alternative choice of lidocaine-loaded liposomes: lidocaine-loaded lipid-polymer hybrid nanoparticles for local anesthetic therapy. Drug Deliv 23:1254–60
   PubMed Web of Science ®Google Scholar
• Wang W, Zhou F, Ge L, et al. (2012). Transferrin-PEG-PE modified dexamethasone conjugated cationic lipid carrier mediated gene delivery system for tumor-targeted transfection. Int J Nanomed 7:2513–22
   PubMed Web of Science ®Google Scholar
• Wang X, Li J, Wang Y, et al. (2009). HFT-T, a targeting nanoparticle, enhances specific delivery of paclitaxel to folate receptor-positive tumors. ACS Nano 3:3165–74
   PubMed Web of Science ®Google Scholar
• Wang Y, Ke CY, Weijie Beh C, et al. (2007). The self-assembly of biodegradable cationic polymer micelles as vectors for gene transfection. Biomaterials 28:5358–68
   PubMed Web of Science ®Google Scholar
• Wang Y, Liu P, Qiu L, et al. (2013). Toxicity and therapy of cisplatin-loaded EGF modified mPEG-PLGA-PLL nanoparticles for SKOV3 cancer in mice. Biomaterials 34:4068–77
   PubMed Web of Science ®Google Scholar
• Wang Y, Zhao B, Wang S, et al. (2016). Formulation and evaluation of novel glycyrrhizic acid micelles for transdermal delivery of podophyllotoxin. Drug Deliv 23:1623–35
   PubMed Web of Science ®Google Scholar
• Ward BB, Dunham T, Majoros IJ, Baker JR Jr (2011). Targeted dendrimer chemotherapy in an animal model for head and neck squamous cell carcinoma. J Oral Maxillofac Surg 69:2452–9
   PubMed Web of Science ®Google Scholar
• Wilken R, Veena MS, Wang MB, Srivatsan ES. (2011). Curcumin: a review of anti-cancer properties and therapeutic activity in head and neck squamous cell carcinoma. Mol Cancer 10:12
   PubMed Web of Science ®Google Scholar
• Wu TT, Zhou SH. (2015). Nanoparticle-based targeted therapeutics in head-and-neck cancer. Int J Med Sci 12:187–200
   PubMed Web of Science ®Google Scholar
• Xie M, Zhang H, Xu Y, et al. (2013). Expression of folate receptors in nasopharyngeal and laryngeal carcinoma and folate receptor-mediated endocytosis by molecular targeted nanomedicine. Int J Nanomed 8:2443–51
   PubMed Web of Science ®Google Scholar
• Zhang C, Peng F, Liu W, et al. (2014). Nanostructured lipid carriers as a novel oral delivery system for triptolide: induced changes in pharmacokinetics profile associated with reduced toxicity in male rats. Int J Nanomed 9:1049–63
   PubMed Web of Science ®Google Scholar
• Zhang G, Liu F, Jia E, et al. (2016). Folate-modified, cisplatin-loaded lipid carriers for cervical cancer chemotherapy. Drug Deliv 23:1393–7
   PubMed Web of Science ®Google Scholar